0001209191-23-054904.txt : 20231109
0001209191-23-054904.hdr.sgml : 20231109
20231109203253
ACCESSION NUMBER: 0001209191-23-054904
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231107
FILED AS OF DATE: 20231109
DATE AS OF CHANGE: 20231109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ENRIGHT PATRICK G
CENTRAL INDEX KEY: 0001253886
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41855
FILM NUMBER: 231394334
MAIL ADDRESS:
STREET 1: CO LONGITUDE CAPITAL PARTNERS LLC
STREET 2: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tammenoms Bakker Juliet
CENTRAL INDEX KEY: 0001431159
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41855
FILM NUMBER: 231394335
MAIL ADDRESS:
STREET 1: LONGITUDE CAPITAL MANAGEMENT CO., LLC
STREET 2: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Longitude Venture Partners IV, L.P.
CENTRAL INDEX KEY: 0001787456
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41855
FILM NUMBER: 231394336
BUSINESS ADDRESS:
STREET 1: 2740 SAND HILL ROAD
STREET 2: 2ND FLOOR
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: (650) 854-5700
MAIL ADDRESS:
STREET 1: 2740 SAND HILL ROAD
STREET 2: 2ND FLOOR
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Longitude Capital Partners IV, LLC
CENTRAL INDEX KEY: 0001829169
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41855
FILM NUMBER: 231394337
BUSINESS ADDRESS:
STREET 1: 2740 SAND HILL ROAD
STREET 2: 2ND FLOOR
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-854-5700
MAIL ADDRESS:
STREET 1: 2740 SAND HILL ROAD
STREET 2: 2ND FLOOR
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lexeo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001907108
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 854012572
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVENUE SOUTH
STREET 2: FLOOR 6
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: (212) 547-9879
MAIL ADDRESS:
STREET 1: 345 PARK AVENUE SOUTH
STREET 2: FLOOR 6
CITY: NEW YORK
STATE: NY
ZIP: 10010
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-07
0
0001907108
Lexeo Therapeutics, Inc.
LXEO
0001829169
Longitude Capital Partners IV, LLC
2740 SAND HILL ROAD
2ND FLOOR
MENLO PARK
CA
94025
0
0
1
0
0001787456
Longitude Venture Partners IV, L.P.
2740 SAND HILL ROAD
2ND FLOOR
MENLO PARK
CA
0
0
1
0
0001431159
Tammenoms Bakker Juliet
C/O LONGITUDE CAPITAL
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK
CA
94025
0
0
1
0
0001253886
ENRIGHT PATRICK G
C/O LONGITUDE CAPITAL
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK
CA
94025
0
0
1
0
0
Common Stock
2023-11-07
4
C
0
1793429
A
1793429
I
By Longitude Venture Partners IV, L.P.
Common Stock
2023-11-07
4
C
0
319126
A
2112555
I
By Longitude Venture Partners IV, L.P.
Common Stock
2023-11-07
4
P
0
454545
11.00
A
2567100
I
By Longitude Venture Partners IV, L.P.
Series A convertible preferred stock
2023-11-07
4
C
0
18999999
D
Common Stock
1793429
0
I
By Longitude Venture Partners IV, L.P.
Series B convertible preferred stock
2023-11-07
4
C
0
2906148
D
Common Stock
319126
0
I
By Longitude Venture Partners IV, L.P.
Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date.
These shares are held by Longitude Venture Partners IV, L.P ("LVP IV"). Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date.
Longitude Capital Partners IV, LLC By: /s/ Cristiana Blauth Oliveira , Authorized Signatory
2023-11-09
Longitude Venture Partners IV, L.P. By: /s/ Cristiana Blauth Oliveira , Authorized Signatory of the General Partner
2023-11-09
/s/ Cristiana Blauth Oliveira, Attorney-in-Fact for Juliet Tammenoms Bakker
2023-11-09
/s/ Cristiana Blauth Oliveira, Attorney-in-Fact for Patrick Enright
2023-11-09